AbbVie (ABBV) EV to EBIT (2013 - 2026)
AbbVie's (ABBV) EV to EBIT stood at 21.29 in Q3 2026, down 52.3% from 44.64 a year earlier and down 18.0% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) EV to EBIT (2013 - 2026) Analysis & Trends
On a TTM basis, AbbVie's EV to EBIT came in at 20.29 as of Sep 30, 2026, down 52.5% year-over-year; for FY2025, it came in at 26.45, down 21.6% from FY2024.
- Across earlier years, EV to EBIT came in at 33.73 in FY2024 (+64.9%), 20.46 in FY2023 (+33.9%), 15.28 in FY2022 (+19.2%) and 12.81 in FY2021 (-19.4%).
- The Q3 2026 figure is the lowest quarterly EV to EBIT since Q4 2023.
- On a year-over-year basis, EV to EBIT has declined for four consecutive quarters, with growth averaging 13.0% over the last eight quarters.
- Peak year-over-year performance for EV to EBIT in the last five years was growth of 80.6% in Q3 2025, against a decline of 52.3% in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 25.97 (Q2 2026), 24.45 (Q1 2026) and 26.45 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 139.96 Bn | 111.95 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 21.29 |
| Jun 30, 2026 | 25.97 |
| Mar 31, 2026 | 24.45 |
| Dec 31, 2025 | 26.45 |
| Sep 30, 2025 | 44.64 |
| Jun 30, 2025 | 29.31 |
| Mar 31, 2025 | 36.24 |
| Dec 31, 2024 | 33.73 |
| Sep 30, 2024 | 24.72 |
| Jun 30, 2024 | 23.62 |
| Mar 31, 2024 | 23.74 |
| Dec 31, 2023 | 20.46 |
| Sep 30, 2023 | 16.59 |
| Jun 30, 2023 | 13.18 |
| Mar 31, 2023 | 16.98 |
| Dec 31, 2022 | 15.28 |
| Sep 30, 2022 | 12.75 |
| Jun 30, 2022 | 15.00 |
| Mar 31, 2022 | 15.05 |
| Dec 31, 2021 | 12.81 |
API Access
AbbVie EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();